2nd Quarter 2025
Key topics in this quarter’s edition include:
- Lenacapavir for HIV pre-exposure prophylaxis
- Wegovy (semaglutide) for treatment of heart failure with preserved ejection fraction and obesity
- Brensocatib for treatment of bronchiectasis
- Tolebrutinib for treatment of non-relapsing secondary progressive multiple sclerosis
- Leqembi SC (lecanemab) for treatment of Alzheimer’s disease